Metabolic Syndrome and COVID-19: Endocrine-Immune Vascular Interactions Shape the Clinical Course
Endocrinology
.
2020 Dec 1;161(12):bqaa131.
doi: 10.1210/endocr/bqaa131.
Authors
Andreas Barthel
1
2
,
Karthikeyan Mohanraj
3
,
Anne Marie Biener
2
,
Stefan R Bornstein
2
4
5
6
Affiliations
1
Medicover, Bochum, Germany.
2
Department of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
3
Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
4
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, University Hospital, Zürich, Switzerland.
5
Division of Diabetes & Nutritional Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
6
Lee Kong Chian School of Medicine, NTU Nanyang Technological University, Singapore, Singapore.
PMID:
33202024
PMCID:
PMC7717211
DOI:
10.1210/endocr/bqaa131
No abstract available
Keywords:
COVID-19; cardiovascular disease; diabetes mellitus; hypertension.
Publication types
Comment
MeSH terms
Betacoronavirus*
COVID-19
Coronavirus Infections*
Humans
Metabolic Syndrome* / epidemiology
Pandemics*
Pneumonia, Viral*
SARS-CoV-2